In our study, despite the correlations observed in active SLE patients, we did not observe any association between OAS2 and CD70 mRNA expression with the presence of clinical manifestations; this was also the case for IL-10, IL-17, and IFN-γ levels. The gene discussed is IL17A; the disease is systemic lupus erythematosus.